ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (845)	1/15/2000 2:10:00 AM
From: scaram(o)uche	Read Replies (1) of 4474

There is no genomics/gene therapy subsector. "Genomics" and "gene therapy" are very different pursuits. Of those companies that you've listed, ARIA is the only gene therapy company. It broke out on the back of old news, in a press release that was timed to induce trading. Traders have been running it ever since, and the CEO is fanning the flames. It's mania, driven largely by those who don't know squat about what they're trading or holding. Not saying it's overvalued at this market cap, and not saying that the mania won't carry it further. If the osteoporosis project isn't as advanced as portrayed by Berger, it's not particularly cheap, IMO. Agreed! Congrats to all long-term longs!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next